MedPath

Conray

2/2023

Approved
Approval ID

1292abfc-496f-4df7-9a08-72072953e1f1

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 11, 2023

Manufacturers
FDA

Liebel-Flarsheim Company LLC

DUNS: 057880002

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

iothalamate meglumine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0019-0953
Application NumberNDA013295
Product Classification
M
Marketing Category
C73594
G
Generic Name
iothalamate meglumine
Product Specifications
Route of AdministrationINTRAVASCULAR
Effective DateOctober 31, 2019
FDA Product Classification

INGREDIENTS (3)

IOTHALAMATE MEGLUMINEActive
Quantity: 600 mg in 1 mL
Code: XUW72GOP7W
Classification: ACTIB
SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORMInactive
Code: 3980JIH2SW
Classification: IACT
EDETATE CALCIUM DISODIUMInactive
Code: 25IH6R4SGF
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Conray - FDA Drug Approval Details